Trademark Search > Trademark Owners > E > Eli Lilly and Company

Eli Lilly and Company Trademarks (2387 records)

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners listed on this page.

Company Trademark Status Update Alerts are email updates of the latest trademarks' status change on company level. Click here to get the alert for FREE!

Page 1 of 120

Goods and Services: Pharmaceutical preparations for the treatment of diabetes
LIVE (Circa: 2018)

Mark Words (NOT AVAILABLE)

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

BATLIGAP

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

BATLIGO

Goods and Services: Computer software application for management of diabetes-related data; insulin pen module uti...
LIVE (Circa: 2018)

WELLDOSE

Goods and Services: Computer software application for management of diabetes-related data; insulin pen module uti...
LIVE (Circa: 2018)

KWIKPAL

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

XUNJEV

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

EMLIRU

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

BEMLIRU

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

BEFINVRA

Goods and Services: Diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agen...
LIVE (Circa: 2018)

NFTYVID

Goods and Services: Diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agen...
LIVE (Circa: 2018)

TAUVID

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

IGNAFIQUE

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

IGNEFIQUE

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

IGNIFIQ

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

IGNAFIQ

Goods and Services: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheime...
LIVE (Circa: 2018)

IGNITIQUE

Goods and Services: Computer software application for management of diabetes-related data; insulin pen module uti...
LIVE (Circa: 2018)

CENSE

Goods and Services: Computer software application for management of diabetes-related data; insulin pen module uti...
LIVE (Circa: 2018)

CERTRUE

Goods and Services: Computer software application for management of diabetes-related data; insulin pen module uti...
LIVE (Circa: 2018)

SYMERSE

Goods and Services: Computer software application for management of diabetes-related data; insulin pen module uti...
LIVE (Circa: 2018)

CONTINUO

Hot News! On Wednesday, March 28, 2018, a U.S. federal trademark registration number 87853734 was filed for CENSE by Eli Lilly and Company with the description Computer software application for management of diabetes-related data; insulin pen module utilizing wireless technology; downloadable cloud computing software for use in managing diabetes.

Hot News! On Wednesday, March 28, 2018, a U.S. federal trademark registration number 87853759 was filed for CERTRUE by Eli Lilly and Company with the description Computer software application for management of diabetes-related data; insulin pen module utilizing wireless technology; downloadable cloud computing software for use in managing diabetes.

Hot News! On Wednesday, March 28, 2018, a U.S. federal trademark registration number 87853773 was filed for SYMERSE by Eli Lilly and Company with the description Computer software application for management of diabetes-related data; insulin pen module utilizing wireless technology; downloadable cloud computing software for use in managing diabetes.

Hot News! On Wednesday, March 28, 2018, a U.S. federal trademark registration number 87853794 was filed for CONTINUO by Eli Lilly and Company with the description Computer software application for management of diabetes-related data; insulin pen module utilizing wireless technology; downloadable cloud computing software for use in managing diabetes.

Hot News! On Wednesday, March 28, 2018, a U.S. federal trademark registration number 87853796 was filed for UNIVOY by Eli Lilly and Company with the description Computer software application for management of diabetes-related data; insulin pen module utilizing wireless technology; downloadable cloud computing software for use in managing diabetes.

Hot News! On Wednesday, March 28, 2018, a U.S. federal trademark registration number 87854394 was filed for by Eli Lilly and Company with the description Pharmaceutical preparations for the treatment of diabetes.

Hot News! On Thursday, April 5, 2018, a U.S. federal trademark registration number 87864323 was filed for IGNAFIQUE by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Thursday, April 5, 2018, a U.S. federal trademark registration number 87864345 was filed for IGNEFIQUE by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Thursday, April 5, 2018, a U.S. federal trademark registration number 87864354 was filed for IGNIFIQ by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Thursday, April 5, 2018, a U.S. federal trademark registration number 87864360 was filed for IGNAFIQ by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Thursday, April 5, 2018, a U.S. federal trademark registration number 87864370 was filed for IGNITIQUE by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Friday, April 6, 2018, a U.S. federal trademark registration number 87865996 was filed for NFTYVID by Eli Lilly and Company with the description Diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases.

Hot News! On Friday, April 6, 2018, a U.S. federal trademark registration number 87866048 was filed for TAUVID by Eli Lilly and Company with the description Diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases.

Hot News! On Monday, April 9, 2018, a U.S. federal trademark registration number 87868931 was filed for WELLDOSE by Eli Lilly and Company with the description Computer software application for management of diabetes-related data; insulin pen module utilizing wireless technology; downloadable cloud computing software for use in managing diabetes.

Hot News! On Monday, April 9, 2018, a U.S. federal trademark registration number 87868963 was filed for KWIKPAL by Eli Lilly and Company with the description Computer software application for management of diabetes-related data; insulin pen module utilizing wireless technology; downloadable cloud computing software for use in managing diabetes.

Hot News! On Monday, April 9, 2018, a U.S. federal trademark registration number 87868968 was filed for XUNJEV by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Monday, April 9, 2018, a U.S. federal trademark registration number 87868973 was filed for EMLIRU by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Monday, April 9, 2018, a U.S. federal trademark registration number 87868977 was filed for BEMLIRU by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Monday, April 9, 2018, a U.S. federal trademark registration number 87869096 was filed for BEFINVRA by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Tuesday, April 10, 2018, a U.S. federal trademark registration number 87870046 was filed for BATLIGAP by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Tuesday, April 10, 2018, a U.S. federal trademark registration number 87870049 was filed for BATLIGO by Eli Lilly and Company with the description Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.

Hot News! On Wednesday, April 11, 2018, a U.S. federal trademark registration number 87873334 was filed for by Eli Lilly and Company with the description Pharmaceutical preparations for the treatment of diabetes.